Clinician recommendations are the most significant factor in driving prostate-specific antigen (PSA) screening in transgender women, according to a study published online Feb. 14 in JAMA Network Open.
Disparities in transgender prostate screening uptake driven by clinicians
Clinician recommendations are the most significant factor in driving prostate-specific antigen (PSA) screening in transgender women, according to a study published online Feb. 14 in JAMA Network Open.